Hypertension in end-stage renal disease: Transplantation

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F18%3A10375589" target="_blank" >RIV/00216208:11130/18:10375589 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11140/18:10375589 RIV/00064203:_____/18:10375589

Result on the web

<a href="https://doi.org/10.1007/978-3-319-31107-4_49" target="_blank" >https://doi.org/10.1007/978-3-319-31107-4_49</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-3-319-31107-4_49" target="_blank" >10.1007/978-3-319-31107-4_49</a>

Result language

angličtina

Original language name

Hypertension in end-stage renal disease: Transplantation

Original language description

Hypertension in children after renal transplantation is an important risk factor not only for graft loss but also for cardiovascular morbidity and mortality. The prevalence of posttransplant HTN ranges between 60% and 90%. The etiology of posttransplant HTN is multifactorial - chronic native kidney disease, immunosuppressive therapy, and chronic allograft dysfunction are the most common causes. Casual blood pressure (BP) should be measured at each outpatient visit; however, ambulatory blood pressure monitoring (ABPM) is the best method for BP evaluation in children after renal transplantation, as it often discloses especially nighttime HTN; given this, it should be regularly performed in each transplanted child. All classes of antihypertensive drugs are used in the treatment of posttransplant HTN because it has never been proven that one class would be better than another. The most commonly used antihypertensives are calcium channel blockers. The target BP for transplant children is still a matter of debate; it is recommended to target the same BP as for healthy children, i.e., 90th percentile. Control of HTN in transplanted children still remains poor - only 20-50% of treated children have normal BP. There is a great potential for improvement of antihypertensive treatment that could potentially result in improvement of both graft and patient survival in children after renal transplantation.

Czech name

—

Czech description

—

Type

C - Chapter in a specialist book

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2018

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name

Pediatric Hypertension

ISBN

978-3-319-31106-7

Number of pages of the result

14

Pages from-to

487-500

Number of pages of the book

881

Publisher name

Springer International Publishing

Place of publication

Cham

UT code for WoS chapter

—